NextCure (NXTC) Earnings Date & Reports

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NXTC is expected to report earnings to rise 2.14% to -190 cents per share on July 30

Q2'26

Est.

$-1.91

Q1'26

Missed

by $1.42

Q4'25

Missed

by $1.89

Q3'25

Missed

by $2.77

Q2'25

Missed

by $10.86

The last earnings report on May 07 showed earnings per share of -187 cents, missing the estimate of -44 cents. With 59.38K shares outstanding, the current market capitalization sits at 7.30M.

View a ticker or compare two or three

Compare

NXTC

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NXTC